Collins Medical Trust is located in Wilsonville, OR. The organization was established in 1958. According to its NTEE Classification (E11) the organization is classified as: Single Organization Support, under the broad grouping of Health Care and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Collins Medical Trust is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2023, Collins Medical Trust generated $843.1k in total revenue. The organization has seen a slow decline revenue. Over the past 7 years, revenues have fallen by an average of (0.7%) each year. All expenses for the organization totaled $680.1k during the year ending 09/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Collins Medical Trust has awarded 115 individual grants totaling $3,646,518. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Truman W Collins Jr Trustee | 1 | $0 | |
Timothy R Bishop Treasurer | 1 | $0 | |
Heather Cashell Administrator | 1 | $0 | |
Virginia Tilden Trustee | 1 | $5,000 | |
John Nutt Trustee | 1 | $5,000 | |
Ryan S Luria Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $0 |
Interest on Savings | $17,634 |
Dividends & Interest | $283,226 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $542,208 |
Capital Gain Net Income | $542,086 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $843,068 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $10,000 |
Other employee salaries and wages | $7,500 |
Pension plans, employee benefits | $0 |
Interest | $0 |
Taxes | $13,133 |
Depreciation | $0 |
Occupancy | $0 |
Travel, conferences, and meetings | $0 |
Printing and publications | $0 |
Other expenses | $1,195 |
Total operating and administrative expenses | $33,039 |
Contributions, gifts, grants paid | $647,056 |
Total expenses and disbursements | $680,095 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $726,874 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $0 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $0 |
Other assets | $0 |
Total assets | $10,957,538 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $66,422 |
Total liabilities | $66,422 |
Over the last fiscal year, Collins Medical Trust has awarded $647,056 in support to 22 organizations.
Grant Recipient | Amount |
---|---|
OHSU FOUNDATION PURPOSE: HEAD AND NECK SQUAMOUS CELL CARCINOMA BONE INVASION EARLY DETECTION AND MECHANISTIC STUDY ON-A-CHIP, CRISTIANE FRANCA, DDS, MS, PHD | $30,000 |
OHSU FOUNDATION PURPOSE: THE ROLE OF PTEN SIGNALING IN THE INTRINSIC CONTROL OF SOMATOSENSORY NEURON DIVERSIFICATION, ALEJANDRA FERNANDEZ, PHD | $30,000 |
OHSU FOUNDATION PURPOSE: LEVERING IMMUNE-RELATED ADVERSE EVENTS TO UNDERSTAND INFLAMMATORY SKIN DISEASE, NOAH HORNICK, MD, PHD | $30,000 |
OHSU FOUNDATION PURPOSE: DIRECT OBSERVATION OF SE-I INTERACTIONS IN IODOTHYRONINE DEIODINASE BY X-RAY ABSORPTION SPECTROSCOPY, KATHERINE RUSH, PHD | $29,972 |
OHSU FOUNDATION PURPOSE: THE DOUBLE-EDGED SWORD OF ENDOPLASMIC RETICULUM STRESS RESPONSES IN PERINATAL CARDIAC MYOCYTE APOPTOSIS, KARTHIKEYAN BOSE, MSC, PHD | $30,000 |
OHSU FOUNDATION PURPOSE: CIRCULATING HYBRID CELLS AS A BIOMARKER OF RESPONSE TO NEO-ADJUVANT CHEMOTHERAPY IN PANCREATIC CANCER, RANISH PATEL, MD | $30,000 |